Catalyst Wire Dossier Catalyst Wire Dossier

VCH-222

· Vertex Pharmaceuticals Incorporated
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VCH-222, covering 2010-01-07 to 2014-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection [Phase 1, Phase 2]

See pricing